Currently, transgender young people in the UK face significant barriers to accessing gender-affirming medical care through the NHS. Following the closure of the Tavistock Gender Identity Development Service and ongoing reviews of clinical guidelines, many young people experience extended waiting periods or limited access to treatments such as puberty blockers and hormone therapy.
Research consistently shows that access to appropriate gender-affirming care can significantly improve mental health outcomes for transgender youth. Evidence indicates that puberty blockers, when clinically appropriate, can provide young people with time to explore their gender identity without the distress of unwanted physical changes. However, current NHS pathways often result in lengthy delays, with some young people waiting years for initial appointments.
The situation varies internationally, with different countries taking varied approaches based on their interpretation of available evidence. Some healthcare systems maintain more accessible pathways for transgender youth, whilst others have implemented additional restrictions or review processes. Guidelines recommend individualised care that considers each young person's specific circumstances, mental health, and family support.
This challenging landscape means many families seek private care or consider treatment abroad. Healthcare professionals emphasise the importance of psychological support and family counselling during this period, recognising that restricted access to medical interventions can contribute to increased anxiety and distress for both young people and their families.